Blue November: what is the initiative aimed at rethinking men’s diseases?

Blue November: what is the initiative aimed at rethinking men's diseases?

Every year, During the month of November we aim to raise awareness about men’s diseases, of which prostate cancer is at the forefront. Since its first edition, in 2017, this prevention campaign has added voices of support that multiply the message of awareness and invite us to break the myths and prejudices that exist around urologist examinations.

In that context, In Formosa, the “Presidente Néstor Kirchner” Nuclear Medicine and Radiotherapy Center is conducting a prevention campaign that will take place throughout the month. In this regard, the entity’s medical director, Fernando Trachta explained that it must be considered that the disease can be “prevented” through hygienic-dietary measures and added that it can also be “controlled”, as long as it is detected in time..

Read Also:  Medical Sciences Campus and Alzheimer's Association team up for a clinical study

Regarding the treatment, the professional indicated that it is a surgical procedure, in cases where it is possible, otherwise hormonal blockages are made to lower the level of hormones that create the possibility of further growth, as highlighted for the Agenfor portal.

Among other resources for the treatment of the disease, Trachta announced that chemotherapies or radiotherapies are also done. “We do cutting-edge treatments, we do abbreviated radiosurgery treatments,” he added.

The disease

“Blue November” is an initiative that aims to raise awareness about comprehensive men’s health care. One of the main milestones of the month is the celebration of World Prostate Cancer Day, which is held every November 17 to raise awareness in society about this disease and inform about the importance of early diagnosis, with resources and possibility for treatment.

Read Also:  Danger to humans from bird flu

Prostate cancer is the most common tumor in men, and in 50% of cases the disease is detected when it is advanced, which increases the risk of mortality. For this reason, the American Society of Urology and the Argentine Society of Urology recommend that all men be examined starting at the age of 45/50, and those with a family history of prostate cancer should start their examination starting at the age of 40 .years.